Portal:Disease/COVIDPathways
From WikiPathways
| Line 4: | Line 4: | ||
<p>This special subset of disease pathways is being highlighted during the current COVID-19 crisis. This content is released under a CC0 waiver to be freely used, reused and distributed. Let us know if you add a new pathway or want to recommend one for this collection.</p> | <p>This special subset of disease pathways is being highlighted during the current COVID-19 crisis. This content is released under a CC0 waiver to be freely used, reused and distributed. Let us know if you add a new pathway or want to recommend one for this collection.</p> | ||
{{#section:Help:Authors|covid-help}} | {{#section:Help:Authors|covid-help}} | ||
| - | |{{#imgLink:Page1-601px-COVID19-Disease-Map-project-icon.pdf.jpg|230|right|Part of the <a href="https://covid.pages.uni.lu/">COVID-19 Disease Map</a> project|external|https://covid.pages.uni.lu/|COVID19 Disease Map}} | + | |{{#imgLink:Page1-601px-COVID19-Disease-Map-project-icon.pdf.jpg|230|right|Part of the <a href="https://covid.pages.uni.lu/">COVID-19 Disease Map</a> project<p>A paper about this project was published in Scientific Data. </p>|external|https://covid.pages.uni.lu/|COVID19 Disease Map}} |
|} | |} | ||
{| style="margin: 10px; background-color:#AFDCDE" | {| style="margin: 10px; background-color:#AFDCDE" | ||
Revision as of 15:54, 14 May 2020
|
This special subset of disease pathways is being highlighted during the current COVID-19 crisis. This content is released under a CC0 waiver to be freely used, reused and distributed. Let us know if you add a new pathway or want to recommend one for this collection. |
 Part of the COVID-19 Disease Map project A paper about this project was published in Scientific Data. |
|
Image does not exist SARS-CoV-2 and COVID-19 Pathway Collaborative project for curation biological processes involved in the COVID-19 disease after SARS-Cov-2 infection. |
Image does not exist Coronavirus lipid metabolism Lipid metabolism alternations that are related to infection by the corona virus. |
Image does not exist Hijack of Ubiquitination by SARS-CoV-2 SARS-CoV-2 includes a novel Orf10 that interacts with muliple members of the Cullin 2 ubiquitin ligase complex. |
Image does not exist Autophagy during CoV infection |
|
Image does not exist Integrative stress response in SARS-CoV-2 infection |
Image does not exist Host-pathogen interaction of human corona viruses - autophagy |
Image does not exist Host-pathogen interaction of human corona viruses - apoptosis |
Image does not exist Type I Interferon Induction and Signaling During SARS-CoV-2 Infection The induction and signaling of type I interferon with specific SARS-CoV-2 protein and relevant drug. |
|
Image does not exist Host-pathogen interaction of human corona viruses - ER stress |
Image does not exist Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV Spike protein |
Image does not exist Activation of NLRP3 Inflammasome by SARS-CoV-2 Orf3a from SARS-CoV has been shown to bind TRAF3 and activate the NLRP3 inflammasome. |
Image does not exist Host-pathogen interaction of human corona viruses - MAPK signaling |
|
Image does not exist Host-pathogen interaction of human corona viruses - Interferon induction |
Image does not exist SARS-CoV-2 and Angiotensin-converting enzyme 2 (ACE2) receptor : Molecular mechanisms and potential therapeutic target |
Image does not exist COVID-19 AOP Experimental pathway to investigate overlap of virus-host interaction and adverse outcome pathways |
Image does not exist nsp9/nsp10-mediated SARS-CoV-2 pathogenesis Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis |
|
Image does not exist LDLRAD4 pathway in COVID-19 |
Image does not exist SARS coronavirus and innate immunity |
Image does not exist COVID-19, thrombosis and anticoagulation |
More about ACE2
|
Image does not exist ACE Inhibitor Pathway |
Image does not exist Metabolism of Angiotensinogen to Angiotensins (Reactome) |
